Apixaban to Prevent Decompensation of Early Liver Cirrhosis Trial | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Apixaban to Prevent Decompensation of Early Liver Cirrhosis Trial	Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder	Not yet recruiting	Phase 3	2026-07-24		NCT07726693

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
BRITISH LIVER TRUST	2
Hull University Teaching Hospitals NHS Trust	32
Imperial College London	220
King's College Hospital NHS Trust	77
King's College London	203
Liverpool University Hospitals NHS Foundation Trust	25
NHS Greater Glasgow and Clyde	44
Royal Free Hospital NHS Foundation Trust	36
The Leeds Teaching Hospitals NHS Trust	36
The Royal London Hospital, UK	2
University College, London	222
University Hospital of Wales	4
University Hospital Southampton NHS Foundation Trust	59
University of Nottingham	109

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.